Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise

被引:132
|
作者
Haorah, J
Heilman, D
Knipe, B
Chrastil, J
Leibhart, J
Ghorpade, A
Miller, DW
Persidsky, Y
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmacol, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA
[3] Univ Nebraska, Med Ctr, Coll Pharm, Omaha, NE 68198 USA
关键词
ethanol; endothelial cell; blood-brain barrier; tight junction; myosin light chain kinase;
D O I
10.1097/01.ALC.0000166944.79914.0A
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Brain endothelial cells form the blood-brain barrier (BBB) that regulates solute and macromolecule flux in and out of the brain, leukocyte migration, and maintains the homeostasis of the central nervous system. BBB dysfunction is associated with disruption of tight junctions (TJ) in the brain endothelium. We propose that alcohol abuse may impair BBB permeability through TJ modification. Methods: Primary cultured bovine brain microvascular endothelial cells (BBMEC) were treated with 50 mM ethanol (EtOH), and monolayer tightness was assessed by measurement of transendothelial electrical resistance (TEER). Changes in TEER were correlated with alterations in TJ protein distribution [occludin, zonula occludens-1 (ZO-1), claudin-5] using immunofluorescence (IF). Expression of myosin light chain (MLC) kinase (MLCK), ZO-1, claudin-5, and phosphorylated MLC, occludin and claudin-5 were determined by immunoprecipitation and Western blot. EtOH-induced changes in monocyte migration across in vitro BBB constructs were also examined. Results: EtOH induced a decrease in TEER of BBMEC monolayers that was reversed by EtOH withdrawal. Treatment of BBMEC with Et01J or its metabolite, acetaldehyde, prior to monocyte application resulted in a 2-fold increase in monocyte migration across the BBB. IF demonstrated decrease in claudin-5 staining, occludin translocation from cell borders to cytoplasm and gap formation in EtOH-treated BBMEC monolayer. These changes paralleled significant increase in phosphorylation of MLC, occludin and claudin-5. EtOH-treated BBMEC showed reduction of total occludin and claudin-5 without changes in ZC-1 or MLC. TEER decrease, changes in occludin/claudin staining, increase in MLC, occludin and claudin-5 phosphorylation and enhanced monocyte migration across the BBB were all reversed by inhibition of MLCK. Inhibition of EtOH metabolism in BBMEC also reversed these events. Conclusion: These results suggest that EtOH activates MLCK leading to phosphorylation of MLC, occludin and claudin-5. Cytoskeletal alterations (MLC) and TJ changes (occludin and claudin-5 phosphorylation) result in BBB impairment (decrease in TEER). TJ compromise is associated with increased monocyte migration across the BBB.
引用
收藏
页码:999 / 1009
页数:11
相关论文
共 50 条
  • [41] Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia
    McCaffrey, Gwen
    Seelbach, Melissa J.
    Staatz, William D.
    Nametz, Nicole
    Quigley, Carolyn
    Campos, Chris R.
    Brooks, Tracy A.
    Davls, Thomas P.
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 (06) : 2395 - 2409
  • [42] MECHANISM OF MMP-9 ACTIVATION OF MYOSIN LIGHT CHAIN KINASE (MLCK) MEDIATED DISRUPTION OF INTESTINAL TIGHT JUNCTION BARRIER
    Al-Sadi, Rana
    Rawat, Manmeet
    Ma, Thomas Y.
    GASTROENTEROLOGY, 2018, 154 (06) : S38 - S38
  • [43] MECHANISM OF MMP-9 ACTIVATION OF MYOSIN LIGHT CHAIN KINASE (MLCK) MEDIATED DISRUPTION OF INTESTINAL TIGHT JUNCTION BARRIER
    Al-Sadi, Rana
    Rawat, Manmeet
    Ma, Thomas
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S26 - S26
  • [44] MECHANISM OF MMP-9 ACTIVATION OF MYOSIN LIGHT CHAIN KINASE (MLCK) MEDIATED DISRUPTION OF INTESTINAL TIGHT JUNCTION BARRIER
    Al-Sadi, Rana
    Rawat, Manmeet
    Ma, Thomas
    GASTROENTEROLOGY, 2018, 154 (01) : S37 - S37
  • [45] Involvement of brain pericytes in cyclosporin A-induced dysfunction of the blood-brain barrier
    Takata, F
    Dohgu, S
    Yamauchi, A
    Niwa, M
    Kataoka, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 89P - 89P
  • [46] Hippocampal Blood-Brain Barrier Damage and Peripheral Vascular Compromise in Schizophrenia Share Endothelial Dysfunction
    Goldwaser, Eric
    Marshall, Wyatt
    Acharya, Nimish
    Kochunov, Peter
    Hong, Elliot
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 356 - 357
  • [47] APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
    Montagne, Axel
    Nation, Daniel A.
    Sagare, Abhay P.
    Barisano, Giuseppe
    Sweeney, Melanie D.
    Chakhoyan, Ararat
    Pachicano, Maricarmen
    Joe, Elizabeth
    Nelson, Amy R.
    D'Orazio, Lina M.
    Buennagel, David P.
    Harrington, Michael G.
    Benzinger, Tammie L. S.
    Fagan, Anne M.
    Ringman, John M.
    Schneider, Lon S.
    Morris, John C.
    Reiman, Eric M.
    Caselli, Richard J.
    Chui, Helena C.
    TCW, Julia
    Chen, Yining
    Pa, Judy
    Conti, Peter S.
    Law, Meng
    Toga, Arthur W.
    Zlokovic, Berislav V.
    NATURE, 2020, 581 (7806) : 70 - +
  • [48] TRPV6 deficient mice are resistant to ethanol-induced disruption of colonic epithelial tight junctions, mucosal barrier dysfunction and liver damage
    Meena, A. S.
    Shukla, P. K.
    Manda, B.
    Amin, S.
    Rao, R. K.
    ALCOHOL, 2018, 66 : 93 - 93
  • [49] Obesity-induced blood-brain barrier dysfunction: phenotypes and mechanisms
    Feng, Ziying
    Fang, Cheng
    Ma, Yinzhong
    Chang, Junlei
    JOURNAL OF NEUROINFLAMMATION, 2024, 21 (01)
  • [50] Blood-brain barrier dysfunction in mice induced by lipopolysaccharide is attenuated by dapsone
    Zhou, Ting
    Zhao, Lei
    Zhan, Rui
    He, Qihua
    Tong, Yawei
    Tian, Xiaosheng
    Wang, Hecheng
    Zhang, Tao
    Fu, Yaoyun
    Sun, Yang
    Xu, Feng
    Guo, Xiangyang
    Fan, Dongsheng
    Han, Hongbin
    Chui, Dehua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 453 (03) : 419 - 424